Home  >  Products  >  ADRA2A (adrenergic, alpha-2A-, receptor ) Blocking Peptide (the C terminal of ADRA2A)(100ug)
ADRA2A (adrenergic, alpha-2A-, receptor ) Blocking Peptide (the C terminal of ADRA2A)(100ug)

ADRA2A (adrenergic, alpha-2A-, receptor ) Blocking Peptide (the C terminal of ADRA2A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ADRA2A Antibody (ARP59965_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59965
Size: 100ug
Weight: 49kDa
Gene: 150
Format: Lyophilized powder
Target: Alpha-2-adrenergic receptors are members of the G protein-coupled receptor superfamily. They include 3 highly homologous subtypes: alpha2A, alpha2B, and alpha2C. These receptors have a critical role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the central nervous system. Studies in mouse revealed that both the alpha2A and alpha2C subtypes were required for normal presynaptic control of transmitter release from sympathetic nerves in the heart and from central noradrenergic neurons; the alpha2A subtype inhibited transmitter release at high stimulation frequencies, whereas the alpha2C subtype modulated neurotransmission at lower levels of nerve activity. This gene encodes alpha2A subtype and it contains no introns in either its coding or untranslated sequences.
Alternative names: ADRA2; ADRA2R; ADRAR; ALPHA2AAR; ZNF32
See Full Product Listings >